Sign in
4

Changes in Ownership

Cytosorbents Corp Filed Acc 0001104659-20-032715

Chief Operating Officer sold 4,677 shares at $6.00 ($28,062)

  • Chief Operating Officer acquired 11,177 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Capponi Vincent · Chief Operating Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2020-03-10 Exercise or conversion : show line 1 in the form +6,500 $3.45 $22,425 417,649 D
2020-03-10 Exercise or conversion : show line 2 in the form +4,677 $3.45 $16,136 422,326 D
2020-03-10 Sale : show line 3 in the form −4,677 $6.00 $28,062 417,649 D
Open-market sales · 4,677 sh · avg $6.00 · $28,062

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2020-03-10 Exercise or conversion : show line 4 in the form Stock Option (right to buy) −6,500 14,800 D
2020-03-10 Exercise or conversion : show line 5 in the form Stock Option (right to buy) −4,677 10,123 D
Loading xslF345X03/tm2011575d4_form4.xml…